Herpes zoster (shingles) vaccination: protocol for a health technology assessment

Health Information and Quality Authority
Record ID 32018005546
Authors' objectives: Herpes zoster, which is commonly known as shingles, affects approximately one in three people that have had chickenpox. Shingles is typically recognised by a painful blistering rash on the torso. While vaccines against herpes zoster are licensed and marketed in Ireland, these vaccines are not included in the Health Service Executive (HSE) national immunisation schedule. The Department of Health requested that HIQA complete a health technology assessment (HTA) to inform a decision on the addition of shingles vaccination to the adult immunisation schedule. The protocol document outlines the evidence synthesis approach that HIQA’s evaluation team will use to complete this piece of work.
Project Status: Ongoing
Anticipated Publish Date: 2024
Requestor: Department of Health
English language abstract: An English language summary is available
Publication Type: Other
Country: Ireland
MeSH Terms
  • Herpes Zoster
  • Mass Vaccination
  • Herpes Zoster Vaccine
  • Adult
  • Vaccination
  • Shingles
  • Vaccination
Organisation Name: Health Information and Quality Authority (HIQA)
Contact Address: Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name: info@hiqa.ie
Contact Email: info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.